C57BL/6NTac-Roratm1a(EUCOMM)Wtsi/Ieg

Status

Available to order

EMMA IDEM:06273
International strain nameC57BL/6NTac-Roratm1a(EUCOMM)Wtsi/Ieg
Alternative nameEPD0157_5_B01
Strain typeTargeted Mutant Strains
Allele/Transgene symbolRoratm1a(EUCOMM)Wtsi
Gene/Transgene symbolRora
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Provider affiliationInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0157_5_B01. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6NTacUSA, wild-type C57BL/6NTacUSA
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased circulating alkaline phosphatase level / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
MGI phenotypes (gene matching)
  • decreased circulating HDL cholesterol level / MGI
  • abnormal vasoconstriction / MGI
  • absent duvet hair / MGI
  • sparse hair / MGI
  • retarded hair growth / MGI
  • tremors / MGI
  • hindlimb paralysis / MGI
  • abnormal olfactory bulb morphology / MGI
  • abnormal cerebellum morphology / MGI
  • small cerebellum / MGI
  • abnormal cerebellar foliation / MGI
  • abnormal cerebellum external granule cell layer morphology / MGI
  • abnormal cerebellar Purkinje cell layer / MGI
  • Purkinje cell degeneration / MGI
  • abnormal Purkinje cell morphology / MGI
  • decreased Purkinje cell number / MGI
  • delaminated Purkinje cell layer / MGI
  • ectopic Purkinje cell / MGI
  • abnormal cerebellar granule layer morphology / MGI
  • absent cerebellar granule layer / MGI
  • abnormal cerebellar molecular layer / MGI
  • thin cerebellar molecular layer / MGI
  • decreased body size / MGI
  • abnormal maternal nurturing / MGI
  • ataxia / MGI
  • hypoactivity / MGI
  • impaired coordination / MGI
  • abnormal gait / MGI
  • abnormal spatial learning / MGI
  • limb grasping / MGI
  • impaired righting response / MGI
  • impaired limb coordination / MGI
  • impaired balance / MGI
  • abnormal vasodilation / MGI
  • abnormal immune system physiology / MGI
  • lung inflammation / MGI
  • reduced female fertility / MGI
  • abnormal estrous cycle / MGI
  • abnormal olfaction / MGI
  • abnormal motor capabilities/coordination/movement / MGI
  • abnormal lipid homeostasis / MGI
  • abnormal brain morphology / MGI
  • abnormal fertility/fecundity / MGI
  • abnormal respiratory mucosa morphology / MGI
  • abnormal lung compliance / MGI
  • abnormal macrophage physiology / MGI
  • increased IgE level / MGI
  • abnormal sexual interaction / MGI
  • abnormal immune system organ morphology / MGI
  • small olfactory bulb / MGI
  • ectopic cerebellar granule cells / MGI
  • abnormal motor learning / MGI
  • abnormal excitatory postsynaptic currents / MGI
  • no phenotypic analysis / MGI
  • abnormal external female genitalia morphology / MGI
  • abnormal nervous system physiology / MGI
  • spleen atrophy / MGI
  • thymus atrophy / MGI
  • abnormal radial glial cell morphology / MGI
  • abnormal inferior olivary complex morphology / MGI
  • abnormal female reproductive system physiology / MGI
  • abnormal hormone level / MGI
  • abnormal cerebellar granule cell morphology / MGI
  • abnormal brain interneuron morphology / MGI
  • abnormal limb posture / MGI
  • abnormal synaptic glutamate release / MGI
  • decreased mean systemic arterial blood pressure / MGI
  • decreased circulating cholesterol level / MGI
  • atherosclerotic lesions / MGI
  • increased susceptibility to atherosclerosis / MGI
  • immune system phenotype / MGI
  • taste/olfaction phenotype / MGI
  • increased angiogenesis / MGI
  • thin cerebellar granule layer / MGI
  • abnormal Purkinje cell dendrite morphology / MGI
  • abnormal Purkinje cell differentiation / MGI
  • increased interleukin-1 secretion / MGI
  • decreased cerebellar granule cell number / MGI
  • delayed estrous cycle / MGI
  • prolonged estrus / MGI
  • prolonged metestrus / MGI
  • reduced cerebellar foliation / MGI
  • abnormal olfactory bulb granule cell morphology / MGI
  • abnormal olfactory bulb layer morphology / MGI
  • abnormal olfactory bulb external plexiform layer morphology / MGI
  • abnormal olfactory bulb glomerular layer morphology / MGI
  • abnormal olfactory bulb granule cell layer morphology / MGI
  • abnormal olfactory bulb internal plexiform layer morphology / MGI
  • abnormal olfactory bulb mitral cell layer morphology / MGI
  • abnormal cerebellar layer morphology / MGI
  • absent cerebellar granule cells / MGI
  • abnormal neuron proliferation / MGI
  • abnormal cerebellum deep nucleus morphology / MGI
  • decreased grip strength / MGI
  • abnormal olfactory bulb outer nerve layer morphology / MGI
  • lethality at weaning, incomplete penetrance / MGI
  • postnatal lethality, complete penetrance / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • abnormal cochlear VIII nucleus morphology / MGI
  • increased noradrenaline level / MGI
  • decreased cerebellar granule cell precursor proliferation / MGI
  • decreased taurine level / MGI
  • decreased gamma-aminobutyric acid level / MGI
  • decreased aspartic acid level / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).